New return-to-play recommendations for athletes with COVID-19November 4, 2020COVID-19 UpdatesHeart FailurePreventive CareLipid Disorders
MADIT-CRT: Resynchronization linked to fewer heart failure hospitalizationsNovember 3, 2020Heart Failure
Novel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesHeart FailureAcute Coronary SyndromesStrokeMixed Topics
When should students resume sports after a COVID-19 diagnosis?October 23, 2020COVID-19 UpdatesPediatricsHeart Failure
Entresto halves renal events in preserved EF heart failure patientsOctober 15, 2020Heart FailureDiabetes
Psychosocial resilience associated with better cardiovascular health in BlacksOctober 7, 2020HypertensionCAD & AtherosclerosisPreventive CareHeart FailureMixed Topics
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020Heart FailureDiabetes
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020Heart FailureDiabetesInterventional Cardiology & Surgery
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020Heart FailureDiabetesCAD & AtherosclerosisInterventional Cardiology & Surgery
